 Zee News |
Erectile dysfunction drug fails for diastolic heart failure patients
EurekAlert (press release) SAN FRANCISCO (March 11, 2013) — Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American College of Cardiology … Viagra `not helpful for heart failure patients`Zee News Viagra is no help against heart failure: studyTimes LIVE Viagra, Aliskiren Not Helpful for Heart Failure After All: StudiesHealth.com Medical Xpress –RedOrbit –MedPage Today all 12 news articles » |
CMV Prevention Drug Fast-Tracked by FDA – Monthly Prescribing Reference
|
CMV Prevention Drug Fast-Tracked by FDA
Monthly Prescribing Reference Phase 2 clinical development of CMX001, for the prevention of CMV infection in adult hematopoietic stem cell transplant (HSCT) recipients, has been completed. Chimeric is planning on initiating SUPPRESS, a Phase 3 study of CMX001 for the prevention of … Chimerix antiviral lands on FDA’s fast trackWRAL Tech Wire Chimerix receives FDA Fast Track designation for CMX001 to prevent CMV …News-Medical.net |
Screenings, targeted care reduce heart failure in at-risk patients – EurekAlert (press release)
|
Screenings, targeted care reduce heart failure in at-risk patients
EurekAlert (press release) SAN FRANCISCO (March 11, 2013) — For at-risk patients, a simple screening and management program can be effective in preventing heart failure, according to research presented today at the American College of Cardiology’s 62nd Annual Scientific … |
Digoxin reduces hospital admissions in older patients with chronic heart failure – EurekAlert (press release)
|
Digoxin reduces hospital admissions in older patients with chronic heart failure
EurekAlert (press release) SAN FRANCISCO (March 11, 2013) —Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction (HFrEF), according to research presented … Simple test can reduce heart failure riskIrish Health Blood Test Plus Targeted Care May Stop Heart Failure Before It StartsHealth.com ACC: Digoxin Cuts 30-Day Admission for Heart FailureDoctors Lounge |
Early treatment for depression after liver transplantation linked to better … – Healio
Early treatment for depression after liver transplantation linked to better …HealioResearchers evaluated 167 patients who underwent liver transplantation (LT) because of alcohol-related liver disease between 1998 and 2003. Symptoms of depression were…
Breast cancer treatment halts bone metastases and also protects bones – Medical Xpress
Breast cancer treatment halts bone metastases and also protects bonesMedical XpressA team of researchers at the MedUni Vienna, led by Michael Gnant from the University Department of Surgery at the MedUni Vienna, has discovered two further positive effe…
MS Patient Website to Provide Most Extensive On-Site Coverage at AAN – PR Web (press release)
 PR Web (press release) |
MS Patient Website to Provide Most Extensive On-Site Coverage at AAN
PR Web (press release) “We’re expecting updates of important trials of oral drugs such as Gilenya, Aubagio and BG-12, as well as the infusion drugs such as Tysabri, alemtuzumab and daclizumab. This information is vital to help people make informed decisions about their … |
Tuberculosis and women: The case of Swaziland. By Alice M Tembe – Pakistan Christian Post
|
Tuberculosis and women: The case of Swaziland. By Alice M Tembe
Pakistan Christian Post … to note that the structural drivers of TB that increase women’s risk of infection in Swaziland are similar to those expressed by Dr Sarabjit Chadha, Project Director at the International Union Against Tuberculosis and Lung Disease (The Union), India. |
R-BAC shows promise in mantle cell lymphoma – Healio
 Healio |
R-BAC shows promise in mantle cell lymphoma
Healio Combination therapy with cytarabine, bendamustine and rituximab was associated with strong response-related outcomes in mantle cell lymphoma, according to results of a phase 2 study. The researchers investigated the R-BAC combination — cytarabine, … |
WuXi Pharmatech and OMT expand antibodies agreement – PMLiVE
|
WuXi Pharmatech and OMT expand antibodies agreement
PMLiVE Chinese contract research organisation (CRO) WuXi Pharmatech and US therapeutic antibodies developer Open Monoclonal Technology (OMT) have agreed to expand WuXi’s use of OMT’s antibodies technology across Asia. The agreement enables WuXi to … |